BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

239 related articles for article (PubMed ID: 29186725)

  • 1. [Screening of executive functions in patients with Parkinson's disease using the new rapid test PAL-5].
    Scheffels JF; Engels JE; Kalbe E; Kessler J
    Fortschr Neurol Psychiatr; 2018 Apr; 86(4):219-225. PubMed ID: 29186725
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Conscious attention defect and inhibitory control deficit in Parkinson's Disease-Mild Cognitive Impairment: A comparison study with Amnestic Mild Cognitive Impairment multiple domain.
    Cammisuli DM; Sportiello MT
    Psychiatr Danub; 2017 Dec; 29(4):437-445. PubMed ID: 29197200
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prospective memory functioning in individuals with Parkinson's disease: a systematic review.
    Costa A; Caltagirone C; Carlesimo GA
    Clin Neuropsychol; 2018 Jul; 32(5):937-959. PubMed ID: 29183225
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Neuropsychological Profiles in Mild Cognitive Impairment due to Alzheimer's and Parkinson's Diseases.
    Hessen E; Stav AL; Auning E; Selnes P; Blomsø L; Holmeide CE; Johansen KK; Eliassen CF; Reinvang I; Fladby T; Aarsland D
    J Parkinsons Dis; 2016 Apr; 6(2):413-21. PubMed ID: 27061068
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Associative reinstatement memory measures hippocampal function in Parkinson's Disease.
    Cohn M; Giannoylis I; De Belder M; Saint-Cyr JA; McAndrews MP
    Neuropsychologia; 2016 Sep; 90():25-32. PubMed ID: 27133526
    [TBL] [Abstract][Full Text] [Related]  

  • 6. CERAD test performance and cognitive impairment in Parkinson's disease.
    Karrasch M; Laatu S; Martikainen K; Marttila R
    Acta Neurol Scand; 2013 Dec; 128(6):409-13. PubMed ID: 23668316
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Measuring executive dysfunction in Parkinson's disease: Reliability and validity of the Spanish version of Frontal Assessment Battery (FAB-E).
    Hurtado-Pomares M; Terol-Cantero MC; Sánchez-Pérez A; Leiva-Santana C; Peral-Gómez P; Valera-Gran D; Navarrete-Muñoz EM
    PLoS One; 2018; 13(11):e0207698. PubMed ID: 30452476
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mild cognitive impairment and cognitive-motor relationships in newly diagnosed drug-naive patients with Parkinson's disease.
    Poletti M; Frosini D; Pagni C; Baldacci F; Nicoletti V; Tognoni G; Lucetti C; Del Dotto P; Ceravolo R; Bonuccelli U
    J Neurol Neurosurg Psychiatry; 2012 Jun; 83(6):601-6. PubMed ID: 22492216
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Differences in cognitive performance in nondemented Parkinson's disease: A latent profile analysis of cognitive subtypes.
    Alonso-Recio L; Martín-Plasencia P; Ruiz M; Serrano JM
    J Clin Exp Neuropsychol; 2018 Oct; 40(8):777-789. PubMed ID: 29429384
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cognitive decline in Parkinson's disease: the impact of the motor phenotype on cognition.
    Wojtala J; Heber IA; Neuser P; Heller J; Kalbe E; Rehberg SP; Storch A; Linse K; Schneider C; Gräber S; Berg D; Dams J; Balzer-Geldsetzer M; Hilker-Roggendorf R; Oberschmidt C; Baudrexel S; Witt K; Schmidt N; Deuschl G; Mollenhauer B; Trenkwalder C; Liepelt-Scarfone I; Spottke A; Roeske S; Wüllner U; Wittchen HU; Riedel O; Dodel R; Schulz JB; Reetz K
    J Neurol Neurosurg Psychiatry; 2019 Feb; 90(2):171-179. PubMed ID: 30297519
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Neuropsychological correlates of prospective memory: A comparison between tremor-dominant Parkinson's disease and cervical dystonia.
    D'Iorio A; Esposito M; Maggi G; Amboni M; Vitale C; Santangelo G
    J Clin Neurosci; 2021 May; 87():156-161. PubMed ID: 33863525
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A new CERAD total score with equally weighted z-scores and additional executive and non-amnestic "CERAD-Plus" tests enhances cognitive diagnosis in patients with Parkinson's disease: Evidence from the LANDSCAPE study.
    Lillig R; Ophey A; Schulz JB; Reetz K; Wojtala J; Storch A; Liepelt-Scarfone I; Becker S; Berg D; Balzer-Geldsetzer M; Kassubek J; Hilker-Roggendorf R; Witt K; Mollenhauer B; Trenkwalder C; Roeske S; Wittchen HU; Riedel O; Dodel R; Kalbe E
    Parkinsonism Relat Disord; 2021 Sep; 90():90-97. PubMed ID: 34418761
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Psychological functioning in Parkinson's disease post-deep brain stimulation: Self-regulation and executive functioning.
    Combs HL; Garcia-Willingham NE; Berry DTR; van Horne CG; Segerstrom SC
    J Psychosom Res; 2018 Aug; 111():42-49. PubMed ID: 29935753
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Impaired frontal lobe functions in patients with Parkinson's disease and psychosis.
    Thota N; Lenka A; George L; Hegde S; Arumugham SS; Prasad S; Stezin A; Kamble N; Yadav R; Pal PK
    Asian J Psychiatr; 2017 Dec; 30():192-195. PubMed ID: 29101795
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The interlocking finger test in patients with Parkinson's disease and healthy subjects.
    Souza CP; Oliveira GN; Foss MP; Tumas V
    J Clin Neurosci; 2016 Jul; 29():145-8. PubMed ID: 26960261
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Sensitive measures of executive dysfunction in non-demented Parkinson's disease.
    Bott NT; Johnson ET; Schuff N; Galifianakis N; Subas T; Pollock J; Pressman P; Kramer JH; Possin KL
    Parkinsonism Relat Disord; 2014 Dec; 20(12):1430-3. PubMed ID: 25454318
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cognitive profile of patients with newly diagnosed Parkinson disease.
    Muslimovic D; Post B; Speelman JD; Schmand B
    Neurology; 2005 Oct; 65(8):1239-45. PubMed ID: 16247051
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cognitive screening in Parkinson's disease: Comparison of the Parkinson Neuropsychometric Dementia Assessment (PANDA) with 3 other short scales.
    Gasser AI; Calabrese P; Kalbe E; Kessler J; Rossier P
    Rev Neurol (Paris); 2016 Feb; 172(2):138-45. PubMed ID: 26494570
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Rapid Eye Movement Sleep Behavior Disorder Symptoms Correlate with Domains of Cognitive Impairment in Parkinson's Disease.
    Zhang JR; Chen J; Yang ZJ; Zhang HJ; Fu YT; Shen Y; He PC; Mao CJ; Liu CF
    Chin Med J (Engl); 2016 Feb; 129(4):379-85. PubMed ID: 26879009
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Automated Indices of Clustering and Switching of Semantic Verbal Fluency in Parkinson's Disease.
    Farzanfar D; Statucka M; Cohn M
    J Int Neuropsychol Soc; 2018 Nov; 24(10):1047-1056. PubMed ID: 30282568
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.